- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Heart Test Laboratories Stock (NASDAQ:HSCS), Quotes and News Summary
Heart Test Laboratories Stock (NASDAQ: HSCS)
| Day Range1.15 - 1.25 | 52 Wk Range1.14 - 6 | Open / Close1.15 / 1.18 | Float / Outstanding6.7M / 8.2M |
| Vol / Avg.11.7K / 1.2M | Mkt Cap9.7M | P/E- | 50d Avg. Price1.77 |
| Div / Yield- | Payout Ratio- | Total Float6.7M | EPS-0.28 |
Earnings
see more| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-21 | ||||||
| REV | |||||||
| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | ||||||
| REV | 3.200K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Heart Test Laboratories Questions & Answers
You can purchase shares of Heart Test Laboratories (NASDAQ: HSCS) through any online brokerage.
Other companies in Heart Test Laboratories’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL), Talis Biomedical (NASDAQ:TLIS) and Tivic Health Systems (NASDAQ:TIVC).
The latest price target for Heart Test Laboratories (NASDAQ: HSCS) was reported by Benchmark on Monday, August 8, 2022. The analyst firm set a price target for 8.00 expecting HSCS to rise to within 12 months (a possible 577.97% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Heart Test Laboratories (NASDAQ: HSCS) is $1.18 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Heart Test Laboratories.
Heart Test Laboratories’s Q2 earnings are confirmed for Monday, November 21, 2022.
There is no upcoming split for Heart Test Laboratories.
Heart Test Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.